MD1568F1 - Method of treatment of the burn disease in the burn shock period - Google Patents

Method of treatment of the burn disease in the burn shock period

Info

Publication number
MD1568F1
MD1568F1 MD20000058A MD20000058A MD1568F1 MD 1568 F1 MD1568 F1 MD 1568F1 MD 20000058 A MD20000058 A MD 20000058A MD 20000058 A MD20000058 A MD 20000058A MD 1568 F1 MD1568 F1 MD 1568F1
Authority
MD
Moldova
Prior art keywords
burn
hours
treatment
chloridephysiologic
rest
Prior art date
Application number
MD20000058A
Other languages
Romanian (ro)
Other versions
MD1568G2 (en
Inventor
Vasile Lutan
Oleg Galbur
Original Assignee
Univ Nicolae Testemitanu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nicolae Testemitanu filed Critical Univ Nicolae Testemitanu
Priority to MDA20000058A priority Critical patent/MD1568G2/en
Publication of MD1568F1 publication Critical patent/MD1568F1/en
Publication of MD1568G2 publication Critical patent/MD1568G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, namely to burn disease treatment in the burn shock period. Summary of the invention consists in application on the burn wound of the bandage moistened with the mixture of medical remedies of following composition, mg/100 ml:hyaluronic acid 500...1000 furacin 20...40 novocaine 1000...1500 dimedrol 80...160 dexamethasone 8...16 heparin 5000...10000 UI contrical 5000...10000 UI sodium chloridephysiologic solution the rest. The bandage is applied to the burn wound in 6-10 hours during 48 hours and at the same time it is carried out the parenteral treatment including the administration of medical remedies composition at the following component ratio, mg/100 ml:hyaluronic acid 500...1000 dexamethason 8...16 glucose 5000...8000 sodium chloridephysiologic solution the rest, which is administered intraperitoneal in 10 hours in the dose of 25 ml/kg during 48 hours.Claims: 1
MDA20000058A 2000-03-28 2000-03-28 Method of treatment of the burn disease in the burn shock period MD1568G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20000058A MD1568G2 (en) 2000-03-28 2000-03-28 Method of treatment of the burn disease in the burn shock period

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20000058A MD1568G2 (en) 2000-03-28 2000-03-28 Method of treatment of the burn disease in the burn shock period

Publications (2)

Publication Number Publication Date
MD1568F1 true MD1568F1 (en) 2000-12-31
MD1568G2 MD1568G2 (en) 2001-06-30

Family

ID=19739571

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20000058A MD1568G2 (en) 2000-03-28 2000-03-28 Method of treatment of the burn disease in the burn shock period

Country Status (1)

Country Link
MD (1) MD1568G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2449795C1 (en) * 2010-11-16 2012-05-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Method of treating chronic pancreatitis

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD481Z (en) * 2011-08-09 2012-09-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for treating I-IIIA-degree burns

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2449795C1 (en) * 2010-11-16 2012-05-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Method of treating chronic pancreatitis

Also Published As

Publication number Publication date
MD1568G2 (en) 2001-06-30

Similar Documents

Publication Publication Date Title
Waldhauser et al. Efficiency and side effects of prostaglandin El in the treatment of erectile dysfunction
ES2164040T1 (en) USE OF AGONISTS OF THE GLICINE UNION SITE OR INHIBITORS OF GLYCIN ABSORPTION FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS.
CA2321700A1 (en) Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
PT913156E (en) USE OF PROTEIN C ACTIVATED TO TREAT HYPERCERAGULATE STATES ASSOCIATED WITH SEPSIA
GB0410266D0 (en) Treatment of apoptosis
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
Schirrmacher Case of cobalt poisoning.
JPH01287041A (en) Sustained release preparation
RU95101385A (en) Products containing g-csf and tnf-binding protein
JP2004537500A5 (en)
RU2007133435A (en) METHOD OF COMBINED TREATMENT AND APPLICABLE FOR THIS COMBINATION OF MEDICINES
Valnes et al. Trimipramine in the treatment of gastric ulcer
KR950031063A (en) Using pravastatin to slow the progression of coronary atherosclerosis
MD1568F1 (en) Method of treatment of the burn disease in the burn shock period
EP1108429A3 (en) An improved amino acid composition for providing an amino acid supplement or protein substitute, particularly for the treatment and/or management of certain diseases
Cassuto et al. Potent inhibition of burn pain without use of opiates
TNSN06072A1 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
JPH07506333A (en) Pyridylguanidine compounds for the treatment of erectile dysfunction
CA2493208A1 (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
JPH08501069A (en) Treatment of pathological hypotension by combined use of cardiotonics and nitric oxide synthesis inhibitors
AR062894A1 (en) FORMULATIONS FOR THERAPEUTIC ESTIMULATION HORMONE THERAPEUTIC ADMINISTRATION (THS)
Levine Advances in the medical therapy of Peyronie's disease: a brief review.
KR930702985A (en) Treatment of Esophageal Cancer
Tomlinson Viagra and its use in cardiovascular disease.